These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7671256)

  • 1. Human c-myb is expressed in cervical carcinomas and transactivates the HPV-16 promoter.
    Nürnberg W; Artuc M; Nawrath M; Lovric J; Stüting S; Moelling K; Czarnetzki BM; Schadendorf D
    Cancer Res; 1995 Oct; 55(19):4432-7. PubMed ID: 7671256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products.
    Nakagoshi H; Kanei-Ishii C; Sawazaki T; Mizuguchi G; Ishii S
    Oncogene; 1992 Jun; 7(6):1233-40. PubMed ID: 1594249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cell-type-specific transcription enhancer of type 16 human papillomavirus (HPV 16)-P97 promoter is defined with HPV-associated cellular events in human epithelial cell lines.
    Taniguchi A; Kikuchi K; Nagata K; Yasumoto S
    Virology; 1993 Aug; 195(2):500-10. PubMed ID: 8393236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
    DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD
    Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
    Patel G; Tantravahi R; Oh IH; Reddy EP
    Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
    Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
    Velazquez Torres A; Gariglio Vidal P
    Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of fibroblast growth factor 2 expression in melanoma cells by the c-MYB proto-oncoprotein.
    Miglarese MR; Halaban R; Gibson NW
    Cell Growth Differ; 1997 Nov; 8(11):1199-210. PubMed ID: 9372243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.
    Nürnberg W; Artuc M; Vorbrueggen G; Kalkbrenner F; Moelling K; Czarnetzki BM; Schadendorf D
    Br J Cancer; 1995 May; 71(5):1018-24. PubMed ID: 7734293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the v-and c-Myb proteins with regulatory sequences of the human c-myc gene.
    Zobel A; Kalkbrenner F; Guehmann S; Nawrath M; Vorbrueggen G; Moelling K
    Oncogene; 1991 Aug; 6(8):1397-407. PubMed ID: 1679531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential binding of nuclear c-ets-1 protein to an intron I fragment of the c-myb gene in growth versus differentiation.
    Wang LG; Liu XM; Li ZR; Denstman S; Bloch A
    Cell Growth Differ; 1994 Nov; 5(11):1243-51. PubMed ID: 7848925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions.
    Kim CY; Tsai MH; Osmanian C; Graeber TG; Lee JE; Giffard RG; DiPaolo JA; Peehl DM; Giaccia AJ
    Cancer Res; 1997 Oct; 57(19):4200-4. PubMed ID: 9331075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of stress response protein glucose regulated protein-78 mediated by c-Myb.
    Ramsay RG; Ciznadija D; Mantamadiotis T; Anderson R; Pearson R
    Int J Biochem Cell Biol; 2005 Jun; 37(6):1254-68. PubMed ID: 15778089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain.
    Hu YL; Ramsay RG; Kanei-Ishii C; Ishii S; Gonda TJ
    Oncogene; 1991 Sep; 6(9):1549-53. PubMed ID: 1923521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.